Acumen Stock Buy Hold or Sell Recommendation

ABOS
 Stock
  

USD 5.72  0.39  7.32%   

Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding Acumen Pharmaceuticals is 'Strong Sell'. Macroaxis provides Acumen Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABOS positions. The advice algorithm takes into account all of Acumen Pharmaceuticals' available fundamental, technical, and predictive indicators you will find on this site.
  
The advice is provided from Acumen Pharmaceuticals' buy-and-hold perspective. Please continue to Acumen Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Acumen and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Acumen Pharmaceuticals.

Execute Acumen Pharmaceuticals Buy or Sell Advice

The Acumen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Acumen Pharmaceuticals. Macroaxis does not own or have any residual interests in Acumen Pharmaceuticals or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Acumen Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Acumen PharmaceuticalsBuy Acumen Pharmaceuticals
Strong Sell

Volatility

Details

Hype Condition

Details

Current Valuation

Details

Odds of Distress

Details

Economic Sensitivity

Details

Analyst Consensus

Details

Reporting Quality (M-Score)

Details
For the selected time horizon Acumen Pharmaceuticals has a Mean Deviation of 5.33, Semi Deviation of 4.79, Standard Deviation of 13.67, Variance of 186.83, Downside Variance of 25.87 and Semi Variance of 22.94
We provide trade advice to complement the prevailing expert consensus on Acumen Pharmaceuticals. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Acumen Pharmaceuticals is not overpriced, please confirm all Acumen Pharmaceuticals fundamentals, including its cash and equivalents, as well as the relationship between the cash flow from operations and number of employees . Given that Acumen Pharmaceuticals has a number of shares shorted of 775.58 K, we suggest you to validate Acumen Pharmaceuticals market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Acumen Pharmaceuticals Trading Alerts and Improvement Suggestions

Acumen Pharmaceuticals has very high historical volatility over the last 90 days
Net Loss for the year was (100.61 M) with loss before overhead, payroll, taxes, and interest of (12.3 M).
Acumen Pharmaceuticals currently holds about 189.91 M in cash with (17.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.69.
Over 77.0% of the company shares are held by institutions such as insurance companies
Latest headline from news.google.com: Flow Chemistry Market Size Will Attain USD 3.9 Billion by 2030 growing at 11.8 percent CAGR - Exclusive Report by Acumen Research and Consulting - Yahoo Finance

Acumen Pharmaceuticals current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Acumen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Acumen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
DescriptionAcumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimers disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc.
Average Consensus Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Acumen Pharmaceuticals Returns Distribution Density

The distribution of Acumen Pharmaceuticals' historical returns is an attempt to chart the uncertainty of Acumen Pharmaceuticals' future price movements. The chart of the probability distribution of Acumen Pharmaceuticals stock daily returns describes the distribution of returns around its average expected value. We use Acumen Pharmaceuticals price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Acumen Pharmaceuticals returns is essential to provide solid investment advice for Acumen Pharmaceuticals.
Mean Return0.40Value At Risk-7.59
Potential Upside6.49Standard Deviation13.67
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Acumen Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Acumen Pharmaceuticals Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Acumen Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Acumen Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Acumen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.24
β
Beta against NYSE Composite2.11
σ
Overall volatility
13.85
Ir
Information ratio 0.0235

Acumen Pharmaceuticals Volatility Alert

Acumen Pharmaceuticals is displaying above-average volatility over the selected time horizon. Investors should scrutinize Acumen Pharmaceuticals independently to ensure intended market timing strategies are aligned with expectations about Acumen Pharmaceuticals volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Acumen Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Acumen Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Acumen Pharmaceuticals Fundamentals Vs Peers

Comparing Acumen Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Acumen Pharmaceuticals' direct or indirect competition across all of the common fundamentals between Acumen Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as Acumen Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Acumen Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing Acumen Pharmaceuticals by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Acumen Pharmaceuticals to competition
FundamentalsAcumen PharmaceuticalsPeer Average
Return On Equity(0.18) %(0.31) %
Return On Asset(0.11) %(0.14) %
Current Valuation29.12 M16.62 B
Shares Outstanding40.93 M571.82 M
Shares Owned by Insiders15.57 %10.09 %
Shares Owned by Institutions77.20 %39.21 %
Number of Shares Shorted775.58 K4.71 M
Price to Book1.17 X9.51 X
Price to Sales538.78 X11.42 X
Gross Profit(12.3 M)27.38 B
EBITDA(19.58 M)3.9 B
Net Income(100.61 M)570.98 M
Cash and Equivalents189.91 M2.7 B
Cash per Share4.69 X5.01 X
Total Debt167 K5.32 B
Current Ratio37.21 X2.16 X
Book Value Per Share4.86 X1.93 K
Cash Flow from Operations(17.96 M)971.22 M
Short Ratio4.82 X4.00 X
Earnings Per Share1.17 X3.12 X
Price to Earnings To Growth(0.23) X4.89 X
Target Price15.83
Number of Employees1418.84 K
Market Capitalization218.13 M19.03 B
Total Asset230.33 M29.47 B
Net Asset230.33 M
   Acquisition by Meisner Derek M of 225000 shares of Acumen Pharmaceuticals subject to Rule 16b-3 [view details]

Acumen Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Acumen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Acumen Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell Acumen Pharmaceuticals? Buying financial instruments such as Acumen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Acumen Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumer Thematic Idea Now

Consumer
Consumer Theme
Funds or Etfs that invest in consumer products such as packaged goods, clothing, food, beverages and retail services. The Consumer theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Acumen Pharmaceuticals Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for analysis

When running Acumen Pharmaceuticals price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Is Acumen Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Acumen Pharmaceuticals. If investors know Acumen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Acumen Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
218.1 M
Return On Assets
(0.11) 
Return On Equity
(0.18) 
The market value of Acumen Pharmaceuticals is measured differently than its book value, which is the value of Acumen that is recorded on the company's balance sheet. Investors also form their own opinion of Acumen Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Acumen Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Acumen Pharmaceuticals' market value can be influenced by many factors that don't directly affect Acumen Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Acumen Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Acumen Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Acumen Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.